Entrada Therapeutics Files 8-K
Ticker: TRDA · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1689375
| Field | Detail |
|---|---|
| Company | Entrada Therapeutics, Inc. (TRDA) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, corporate-update
TL;DR
Entrada Therapeutics filed an 8-K on 2/24/25 covering Reg FD, other events, and financials.
AI Summary
Entrada Therapeutics, Inc. filed an 8-K on February 24, 2025, reporting on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. The company, formerly known as CycloPorters, Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This 8-K filing provides a snapshot of recent corporate activities and disclosures for Entrada Therapeutics, Inc., which could be relevant for investors monitoring the company's regulatory compliance and operational updates.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain significant negative news or events.
Key Numbers
- 001-40969 — SEC File Number (Identifies the company's filing with the SEC)
- 813983399 — IRS Number (Company's Employer Identification Number)
Key Players & Entities
- Entrada Therapeutics, Inc. (company) — Registrant
- CycloPorters, Inc. (company) — Former company name
- February 24, 2025 (date) — Date of earliest event reported
- Boston, MA (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Entrada Therapeutics, Inc.?
The primary purpose is to report on Regulation FD disclosures, other events, and financial statements and exhibits as of February 24, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 24, 2025.
What was Entrada Therapeutics, Inc. formerly known as?
Entrada Therapeutics, Inc. was formerly known as CycloPorters, Inc.
Where are Entrada Therapeutics, Inc.'s principal executive offices located?
Entrada Therapeutics, Inc.'s principal executive offices are located at One Design Center Place, Suite 17-500, Boston, MA 02210.
What is the SEC file number for Entrada Therapeutics, Inc.?
The SEC file number for Entrada Therapeutics, Inc. is 001-40969.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Entrada Therapeutics, Inc. (TRDA).